SORT1 and cancer: In this work, sortilin is selected as a cancer‐related LTR, due to its efficient lysosomal transport capabilities, high expression in cancers, and limited distribution in normal tissues outside the nervous system.[16] Using the AlphaFold‐Multimer algorithm,[17] we identified specific protein binders to direct MPs to the lysosome in a sortilin‐dependent manner.